Global Biosimilars Market Growing to Exhibit a Noteworthy CAGR of 22.9% by 2033, Key Drivers, Growth and Opportunity Analysis - Research Nester
October 12, 2022 09:50 ET
|
Research Nester
New York, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Research Nester has published a detailed market report on ‘Global Biosimilars Market’ for the forecast period, i.e. 2023 – 2033 which includes the...
Biosimilars Market to reach a size of US$ 100.5 Bn by the end of 2032
September 27, 2022 09:30 ET
|
Persistence Market Research
New York, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Rapid growth of the pharmaceutical realm and higher prices of existing biological drugs are likely to foster attractive growth avenues in the biosimilars...
Global Biosimilars Market Size is Projected to Gain USD 103.94 Billion, at a CAGR of 25.6% by 2022 to 2028 | Vantage Market Research
September 21, 2022 07:28 ET
|
Vantage Market Research
WASHINGTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Biosimilars Market finds that the increasing chronic diseases and rising cost effectiveness of...
Biosimilars Market worth $44.7 billion by 2026 - Exclusive Report by MarketsandMarkets™
July 26, 2022 10:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, July 26, 2022 (GLOBE NEWSWIRE) -- Biosimilars Market size is projected to reach USD 44.7 billion by 2026 from USD 15.6 billion in 2021, at a CAGR of 23.5% during the forecast period of 2021...
With 21.5% CAGR, Global Biosimilars Market Size Worth USD 87.12 Billion in 2030, Growth Plus Reports
July 05, 2022 08:06 ET
|
Growth Plus Reports
Pune, July 05, 2022 (GLOBE NEWSWIRE) -- The Global Biosimilars Market is expected to clock US$ ~87.12 billion by 2030 due to a robust pipeline for biosimilars and increasing demand for biosimilars....
Biosimilars Market is estimated to value over USD 91 Billion by 2030 | MDC Research Study
April 05, 2022 09:42 ET
|
Market Data Centre
Pune, April 05, 2022 (GLOBE NEWSWIRE) -- The global biosimilars market is driven by cost effectiveness of drug due to which there is a increase demand of biosimilar drugs. Moreover, diverse...
Global Biosimilars Market is estimated close to $18 billion (2020), growing at a Double-Digit Rate
March 07, 2022 08:45 ET
|
Medi-Tech Insights
BRUSSELS, Belgium, March 07, 2022 (GLOBE NEWSWIRE) -- Summary: Medi-Tech Insights: The biosimilars market growth is driven by growing number of biosimilar approvals and rising number of...
Biosimilars Market to Reach USD 103.94 Billion by 2028 - Low Priced Biosimilars to Boost the Market Demand – Vantage Market Research
February 14, 2022 03:39 ET
|
Vantage Market Research
WASHINGTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- The Global Biosimilars Market size is expected to reach USD 103.94 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 25.6% during the...
Biosimilars Market Size to Surpass US$ 66.2 Billion by 2030
November 18, 2021 11:00 ET
|
Precedence Research
Ottawa, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The global biosimilars market size was reached at US$ 13.2 billion in 2020. The rising prevalence of diseases and the effective treatment of these chronic...
Global Biosimilars Market Is Estimated to Grow at a CAGR of +6% by 2025 Top Companies are Pfizer, Sandoz, Teva Pharmaceuticals, Amgen, Biocon, Dr. Reddy’s Laboratories, Celltrion
July 05, 2019 05:50 ET
|
Global Reports Store
PUNE, India, July 05, 2019 (GLOBE NEWSWIRE) -- Global Biosimilars Industry was valued at USD $7.75 Billion in the year 2019. Global Biosimilars Industry is further estimated to grow at a CAGR of...